Trial Profile
An Open Clinical Trial to Evaluate Danoprevir Sodium Tablets Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jun 2020
Price :
$35
*
At a glance
- Drugs Danoprevir (Primary) ; Ritonavir (Primary)
- Indications COVID 2019 infections; Pneumonia; Respiration disorders
- Focus Adverse reactions
- 01 Jun 2020 Status changed from recruiting to completed.
- 16 Apr 2020 New trial record